iHerb Expands Consumer Benefits Across Asia with 618 Shopping Festival
Trade Compliance Records Addresses June 2026 Executive Order Broker Liability
Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth
Central Asia visit drives multi-sector collaboration, Business delegation signed 66 MoUs and agreements to seize Belt and Road opportunities
Custom Health Holdings Inc. Announces Completion of Plan of Arrangement
BOSTON, March 23, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology…
BETHESDA, Md., March 23, 2022 (GLOBE NEWSWIRE) — Bethesda, Maryland- and Dijon, France-based food safety…
MINNEAPOLIS, March 23, 2022 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical…
Results Demonstrated Anti-BCMA CAR T Cells Derived from Healthy Donors Had Better Immune Fitness and…
Burel to support anthrax and RapidVax™ biodefense initiatives as a platform for rapid response to…
SAN CARLOS, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a…
SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage…
Company to participate in live panel, “Pancreatic Cancer: Turning the Tide for One of the…
Arecor Therapeutics plc(“Arecor” or the “Group”) ARECOR GRANTED KEY U.S. PATENT PROTECTING PROPRIETARY INSULIN PRODUCTS…
Glen Rock, N.J., March 23, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
SAN JOSE, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage company…
ARLINGTON, Mass., March 23, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical…
Topline Phase 1 data for our allosteric TYK2 inhibitor, VTX958, expected in early Q3 2022…
David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry…
-Frank Tufaro, Ph.D., appointed as Chief Operating Officer of Synthetic Biologics, transitioning from Chief Operating…
LONDON and PHOENIX, March 23, 2022 (GLOBE NEWSWIRE) — AccuStem Sciences, Inc. (OTC Pink: ACUT),…
MALVERN, Pa., March 23, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage biotechnology company…
— Apraglutide, a next-generation GLP-2 analog, protected against chemotherapy-induced gastrointestinal (GI) damage and improved survival…
Results show the potential in the use of PLX-R18 for meaningful advantage over other existing…